The US FDA has issued a product safety alert and recommended a compounding pharmacy cease manufacturing operations after observing unsanitary conditions at a Californian facility.
Lonza has been contracted to develop a production process for a hepatitis C drug being trialled by gene silencing firm Benitec Biopharma.
Contractor Trenzyme GmbH has licensed a CHO cell line-based expression system from Swiss firm Celonic AG in a deal designed to expand its service offering.
AmerisourceBergen has announced plans to buy drug compounding firm PharMEDium Healthcare Holdings from private equity group, Clayton, Dubilier & Rice.
Evotec has been hired to manage candidate drug compounds by the US National Cancer Institute (NCI) under an agreement the CRO hopes will help it win further contracts.
BASF expects to reduce its workforce though natural employee turnover rather than redundancies as part of a new €1bn cost cutting plan.
Got experience in endocrinology and metabolism indications R&D? Chiltern has added a new offering and says it is looking to hire.